11. CTNI-04. RECURRENT GLIOBLASTOMA LONG-TERM SURVIVORS TREATED WITH CUSP9v3. (12th November 2021) Authors: Halatsch, Marc-Eric; Kast, Richard; Karpel-Massler, Georg; Mayer, Benjamin; Zolk, Oliver; Schmitz, Bernd; Scheuerle, Angelika; Maier, Ludwig; Bullinger, Lars; Mayer-Steinacker, Regine; Schmidt, Carl; Zeiler, Katharina; Elshaer, Ziad; Panther, Patricia; Schmelzle, Birgit; Hallmen, Anke; Dwucet, An... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care. Issue 12 (December 2018) Authors: Döhner, Hartmut; Dolnik, Anna; Tang, Lin; Seymour, John; Minden, Mark; Stone, Richard; del Castillo, Teresa; Al-Ali, Haifa; Santini, Valeria; Vyas, Paresh; Beach, C.; MacBeth, Kyle; Skikne, Barry; Songer, Steve; Tu, Nora; Bullinger, Lars; Dombret, Hervé Journal: Leukemia Issue: Volume 32:Issue 12(2018) Page Start: 2546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Cytotoxic Effects of Rabbit Anti-thymocyte Globulin Preparations on Primary Human Thymic Epithelial Cells. Issue 11 (November 2019) Authors: Kaebisch, Eva M.; Cho, Mi-Young; Oh, Young-Seong; Olfe, Lisa I.; Szyska, Martin; Becker, Sonya C.; Reinke, Petra; Volk, Hans-Dieter; Gillissen, Bernhard; Bullinger, Lars; Thiel, Andreas; Na, Il-Kang Journal: Transplantation Issue: Volume 103:Issue 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights. (September 2010) Authors: Claus, Rainer; Plass, Christoph; Armstrong, Scott A; Bullinger, Lars Journal: Future oncology Issue: Volume 6:Number 9(2010) Page Start: 1415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia. Issue 5 (4th May 2018) Authors: Bohl, Stephan R.; Bullinger, Lars; Rücker, Frank G. Journal: Expert review of hematology Issue: Volume 11:Issue 5(2018) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Expression of CD274 (PD‐L1) is associated with unfavourable recurrent mutations in AML. (19th December 2017) Authors: Zajac, Malgorzata; Zaleska, Joanna; Dolnik, Anna; Bullinger, Lars; Giannopoulos, Krzysztof Journal: British journal of haematology Issue: Volume 183:Number 5(2018) Page Start: 822 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cells. Issue 7 (3rd April 2018) Authors: Penter, Livius; Dietze, Kerstin; Bullinger, Lars; Westermann, Jörg; Rahn, Hans‐Peter; Hansmann, Leo Journal: European journal of immunology Issue: Volume 48:Issue 7(2018) Page Start: 1248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma. (31st December 2022) Authors: Schmiester, Maren; Maier, René; Riedel, René; Durek, Pawel; Frentsch, Marco; Kolling, Stefan; Mashreghi, Mir-Farzin; Jenq, Robert; Zhang, Liangliang; Peterson, Christine B.; Bullinger, Lars; Chang, Hyun-Dong; Na, Il-Kang Journal: Gut microbes Issue: Volume 14:Isuse 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Gene Expression Profiling Predicts Sensitivity of Chronic Lymphocytic Leukemia Cells to Dasatinib. Issue 1 (16th January 2021) Authors: Blätte, Tamara J.; Machnicki, Marcin M.; Glodkowska-Mrowka, Eliza; Dolnik, Anna; Karp, Marta; Karczmarczyk, Agnieszka; Giannopoulos, Krzysztof; Bullinger, Lars; Stoklosa, Tomasz Journal: HemaSphere Issue: Volume 5:Issue 1(2021) Page Start: e514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. Issue 10 (October 2019) Authors: Weller, Johannes; Tzaridis, Theophilos; Mack, Frederic; Steinbach, Joachim Peter; Schlegel, Uwe; Hau, Peter; Krex, Dietmar; Grauer, Oliver; Goldbrunner, Roland; Bähr, Oliver; Uhl, Martin; Seidel, Clemens; Tabatabai, Ghazaleh; Brehmer, Stefanie; Bullinger, Lars; Galldiks, Norbert; Schaub, Christin... Journal: Lancet oncology Issue: Volume 20:Issue 10(2019) Page Start: 1444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗